Ugt1a1 guided cancer therapy: review of the evidence and considerations for clinical implementation

HIGHLIGHTS

  • who: Ryan S. Nelson and collaborators from the Department of Consultative Services, ARUP Laboratories, Salt Lake City, UT, USADepartment of Pharmacotherapy and Translational Research, The University of Florida have published the research: UGT1A1 Guided Cancer Therapy: Review of the Evidence and Considerations for Clinical Implementation, in the Journal: Cancers 2021, 13, x Cancers 2021, 13, 1566 of /2021/
  • what: Some of the studies identified in the review proposed that UGT1A1 results may help avoid treatment delays and adverse events, but there is a lack of implementation studies assessing UGT1A1-guided nilotinib prescribing.
  • future . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?